期刊文献+

导流杂交基因芯片技术检测人乳头瘤病毒结果分析 被引量:4

Flow-through hybridization detection of human papillomavirus DNA microarray analysis
下载PDF
导出
摘要 目的分析妇产科就诊妇女人乳头瘤病毒(HPV)感染、基因型和年龄特征的流行病学情况。方法对2008年1月—2012年12月妇产科就诊的6230例妇女进行下生殖道HPV感染分型检测,采用核酸分子快速导流杂交基因芯片技术(HybriMax)检测21种亚型,其中高危型(HR-HPV)15种,低危型(LR-HPV)6种。结果在6230例标本中,阳性标本1664(26.71%),单型感染1213例(19.47%),多型感染451例(7.24%)。感染率占前5位的亚型分别是:HPV16型335例(5.38%)、HPV52型334例(5.36%)、HPV58型243例(3.90%)、HPV6型164例(2.63%)、HPV53型152例(2.44%)。高危型HPV16、HPV52和HPV58及低危型HPV8304和HPV11检出率逐年下降;所有患者中≤20岁年龄段HPV检出率最高为52.04%。结论应用HybriMax技术检测HPV的检出率为26.71%,主要为HPV16、HPV52、HPV58、HPV6和HPV53,人群感染高峰在≤20岁年龄段。 Objective To analysis clinic analysis of human papilloma virus(HPV) infection,genotype and age characteristics of the epidemiological situation in obstetrics and gynecology.Methods From January 2008 to December 2012,6230 cases of obstetrics and gynecology clinic for lower genital tract of women infected with HPV genotyping were investigated,using nucleic acid molecules,hybridization and gene chip deflector(HybriMax) detected 21 kinds of subtypes,including 15kinds of high-risk(HR-HPV) and 6 low-risk(LR-HPV).Results In 6230 cases of specimens,positive samples 1664(26.71%),single infection 1213 cases(19.47%),more than 451 cases of infection(7.24%).Infection accounted for the top five subtypes are:HPV16 type 335 cases(5.38%),HPV52 type 334 cases(5.36%),HPV58 type 243 cases(3.90%),HPV6 type 164 cases(2.63%),and HPV53 type 152 cases(2.44%).High-risk HPV16,HPV52 and HPV58 and HPV11low risk HPV8304 detection rate and declining;all patients aged ≤ 20 HPV detection rate up to 52.04%.Conclusion Application of HybriMax to detect HPV,the detecUon rate is 26.71%,mainly for HPV16,HPV52,HPV58,HPV6 and HPV53,people infected with the peak at age≤ 20 years of age.
出处 《疑难病杂志》 CAS 2013年第11期865-867,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 人乳头瘤病毒 宫颈癌 快速导流杂交基因芯片技术 Human papilloma virus Cervical cancer HybriMax
  • 相关文献

参考文献11

二级参考文献123

共引文献220

同被引文献56

  • 1陶萍萍,卞美璐,欧华,陈庆云,李敏,刘军.导流杂交基因芯片技术在人乳头状瘤病毒检测中应用的研究[J].中华妇产科杂志,2006,41(1):43-47. 被引量:132
  • 2SiddiqaA, Zainab M, Qadri I, et al. Prevalence and genotyping of high risk human papillomavirus in cervi- cal cancer samples from punjab, pakistan [J]. Viruses, 2014, 6(7):2762-2767.
  • 3Berman NR. Cervical cancer screening today. The role of HPV DNA testing [J]. Advance For Nurse Practition- ers, 2006, 14(4):24-29.
  • 4Bray F, Ren JS, Masuyer E, et al. Global estimates of cancerprevalence for 27 sites in the adult population in 2008[J]. Int J Cancer, 2013, 132(5):1133-1145.
  • 5Yildirim JG, Arabaci Z. Innovations in HPV vaccination and roles of nurses in cervical cancer prevention [J]. Asian Pac J Cancer Prev, 2014, 15(23):10053-10056.
  • 6Demir F, Kimiloglu E, Igdem AA, et al. High risk HPV in situ hybridization, p16 INK 4A, and survivin expres- sions in cervical carcinomas and intraepithelial neo- plasms evaluation of prognostic factors [J]. Eur J Gy- naecol Oncol, 2014, 35(6):708-717.
  • 7Ronco G, Dillner J, Elfstr6m KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised con- trolled trials[J]. The Lancet, 2014, 383(9916):524-532.
  • 8Canales NA, Marina VM, Castro JS, et al. A1BG and C3 are overexpressed in patients with cervical intraep- ithelial neoplasia lU [J]. Oncol Lett, 2014, 8(2):939-947.
  • 9Park JS, Kim YT, Lee A, et al. Prevalence and type dis- tribution of human papillomavirus in cervicall adenocar- cinoma in Korean womenn [J]. Gynecol Oncol, 2013, 130(1):115-120.
  • 10Cuschieri K, Brewster DH, Graham C, et al. Influence of HPV type on prognosis in patients diagnosed with in- vasive cervical cancer[J]. Int J Cancer, 2014, 135(11): 2721-2726.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部